Doxorubicin (DOX) remains a cornerstone of cancer therapy but is limited by dose-dependent cardiotoxicity with inadequate protective strategies. Nerve injury-induced protein 1 (NINJ1), a regulator of inflammation and cell death, has not been explored in this context. We sought to define the role of NINJ1 in DOX-induced cardiotoxicity and evaluate its translational potential.
Results:
Using complementary genetic, pharmacologic, and transcriptomic approaches, we demonstrate that NINJ1 is markedly upregulated in DOX-treated murine hearts and cardiomyocytes. Cardiomyocyte-specific NINJ1 deletion confers robust protection against cardiac dysfunction, oxidative stress, and apoptosis, whereas NINJ1 overexpression exacerbates injury. Mechanistically, NINJ1 suppresses AMP-activated protein kinase (AMPK) activation, promoting ubiquitin-mediated degradation of hypoxia-inducible factor-1α (HIF-1α), thereby impairing antioxidant gene programs. Multilevel evidence, including RNA sequencing, pathway enrichment, and gain- and loss-of-function models, establishes the NINJ1-AMPK-HIF-1α axis as a central regulator of redox homeostasis. Pharmacologic inhibition of NINJ1 with phenyl-β-D-glucopyranoside attenuates cardiac injury in vivo and in vitro without compromising DOX antitumor efficacy, supporting pathway specificity and therapeutic feasibility.
Innovation:
This study identifies NINJ1 as a previously unrecognized driver of anthracycline cardiotoxicity and uncovers a novel signaling axis linking membrane injury signaling to metabolic control of HIF-1α stability.
Conclusions:
NINJ1 promotes DOX-induced cardiotoxicity by destabilizing HIF-1α via AMPK inhibition. Targeting NINJ1 represents a promising cardioprotective strategy.
Clinical Significance:
Therapeutic inhibition of NINJ1 protects the heart while preserving anticancer efficacy, offering a potential strategy to enhance the safety of anthracycline-based chemotherapy and improve outcomes in cancer patients. Antioxid. Redox Signal. 00, 000–000.
Abdel MalikR, ZippelN, FRöMELT, et al.AMP-activated protein kinase α2 in neutrophils regulates vascular repair via hypoxia-inducible factor-1α and a network of proteins affecting metabolism and apoptosis. Circ Res2017;120(1):99–109; doi: 10.1161/circresaha.116.309937
2.
AhnBJ, LeeHJ, ShinMW, et al.Ninjurin1 is expressed in myeloid cells and mediates endothelium adhesion in the brains of EAE rats. Biochem Biophys Res Commun2009;387(2):321–325; doi: 10.1016/j.bbrc.2009.07.019
3.
ArakiT, MilbrandtJ. Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth. Neuron1996;17(2):353–361; doi: 10.1016/s0896-6273(00)80166-x
4.
ArakiT, ZimonjicDB, PopescuNC, et al.Mechanism of homophilic binding mediated by ninjurin, a novel widely expressed adhesion molecule. J Biol Chem1997;272(34):21373–21380; doi: 10.1074/jbc.272.34.21373
5.
BerkelC, CacanE. Lower expression of NINJ1 (Ninjurin 1), a mediator of plasma membrane rupture, is associated with advanced disease and worse prognosis in serous ovarian cancer. Immunol Res2023;71(1):15–28; doi: 10.1007/s12026-022-09323-7
6.
CardinaleD, ColomboA, BacchianiG, et al.Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation2015;131(22):1981–1988; doi: 10.1161/circulationaha.114.013777
7.
ChenJS, Coustan-SmithE, SuzukiT, et al.Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia. Blood2001;97(7):2115–2120; doi: 10.1182/blood.v97.7.2115
8.
ChenL, LiuT, ZhangS, et al.Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro. J Ovarian Res2014;7:115; doi: 10.1186/s13048-014-0115-1
9.
ChenS, YinC, LaoT, et al.AMPK-HDAC5 pathway facilitates nuclear accumulation of HIF-1α and functional activation of HIF-1 by deacetylating Hsp70 in the cytosol. Cell Cycle2015;14(15):2520–2536; doi: 10.1080/15384101.2015.1055426
10.
ChenSY, ShyuIL, ChiJT. NINJ1 in cell death and ferroptosis: Implications for tumor invasion and metastasis. Cancers (Basel)2025;17(5):800; doi: 10.3390/cancers17050800
11.
ChenY, ShiS, DaiY. Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy. Biomed Pharmacother2022;156:113903; doi: 10.1016/j.biopha.2022.113903
12.
ChoiYY, KimMH, HanJM, et al.The anti-inflammatory potential of cortex phellodendron in vivo and in vitro: Down-regulation of NO and iNOS through suppression of NF-κB and MAPK activation. Int Immunopharmacol2014;19(2):214–220; doi: 10.1016/j.intimp.2014.01.020
DegenM, SantosJC, PluhackovaK, et al.Structural basis of NINJ1-mediated plasma membrane rupture in cell death. Nature2023;618(7967):1065–1071; doi: 10.1038/s41586-023-05991-z
15.
DoroshowJH, LockerGY, MyersCE. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: Alterations produced by doxorubicin. J Clin Invest1980;65(1):128–135; doi: 10.1172/jci109642
16.
EkanayakeP, AhnM, KimJ, et al.Immunohistochemical localization of nerve injury-induced protein-1 in mouse tissues. Anat Cell Biol2019;52(4):455–461; doi: 10.5115/acb.19.144
17.
EvavoldCL, RuanJ, TanY, et al.The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages. Immunity2018;48(1):35–44.e6; doi: 10.1016/j.immuni.2017.11.013
18.
GuJ, FanY, LiuX, et al.SENP1 protects against myocardial ischaemia/reperfusion injury via a HIF1α-dependent pathway. Cardiovasc Res2014;104(1):83–92; doi: 10.1093/cvr/cvu177
19.
HalliganDN, MurphySJ, TaylorCT. The Hypoxia-Inducible Factor (HIF) couples immunity with metabolism. Semin Immunol2016;28(5):469–477; doi: 10.1016/j.smim.2016.09.004
20.
HuC, ZhangX, SongP, et al.Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway. Redox Biol2020a;37:101747; doi: 10.1016/j.redox.2020.101747
21.
HuC, ZhangX, ZhangN, et al.Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin-induced cardiotoxicity. Clin Transl Med2020b;10(3):e124; doi: 10.1002/ctm2.124
22.
HwangSJ, LeeHJ. Phenyl-β-D-glucopyranoside exhibits anti-inflammatory activity in lipopolysaccharide-activated RAW 264.7 cells. Inflammation2015;38(3):1071–1079; doi: 10.1007/s10753-014-0072-2
23.
HyunSY, MinHY, LeeHJ, et al.Ninjurin1 drives lung tumor formation and progression by potentiating Wnt/β-Catenin signaling through Frizzled2-LRP6 assembly. J Exp Clin Cancer Res2022;41(1):133; doi: 10.1186/s13046-022-02323-3
24.
JeonS, KimTK, JeongSJ, et al.Anti-inflammatory actions of soluble ninjurin-1 ameliorate atherosclerosis. Circulation2020;142(18):1736–1751; doi: 10.1161/circulationaha.120.046907
25.
KayagakiN, StoweIB, AlegreK, et al.Inhibiting membrane rupture with NINJ1 antibodies limits tissue injury. Nature2023;618(7967):1072–1077; doi: 10.1038/s41586-023-06191-5
KimJW, MoonAR, KimJH, et al.Up-regulation of ninjurin expression in human hepatocellular carcinoma associated with cirrhosis and chronic viral hepatitis. Mol Cells2001;11(2):151–157.
28.
KitazumiI, TsukaharaM. Regulation of DNA fragmentation: The role of caspases and phosphorylation. Febs J2011;278(3):427–441; doi: 10.1111/j.1742-4658.2010.07975.x
29.
KrügerDN, BosmanM, VAN CraenenbroeckEM, et al.Dexrazoxane prevents vascular toxicity in doxorubicin-treated mice. Cardiooncology2024;10(1):65; doi: 10.1186/s40959-024-00270-w
30.
KuzuM, KandemirFM, YildirimS, et al.Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidative stress, inflammation and apoptosis. Biomed Pharmacother2018;106:443–453; doi: 10.1016/j.biopha.2018.06.161
31.
LeeC, XinG, LiF, et al.Calcium/P53/Ninjurin 1 signaling mediates plasma membrane rupture of acinar cells in severe acute pancreatitis. Int J Mol Sci2023;24(14):11554; doi: 10.3390/ijms241411554
32.
LeeHJ, AhnBJ, ShinMW, et al.Ninjurin1: A potential adhesion molecule and its role in inflammation and tissue remodeling. Mol Cells2010;29(3):223–227; doi: 10.1007/s10059-010-0043-x
33.
LeeHJ, AhnBJ, ShinMW, et al.Ninjurin1 mediates macrophage-induced programmed cell death during early ocular development. Cell Death Differ2009;16(10):1395–1407; doi: 10.1038/cdd.2009.78
34.
LeeSH, GolinskaM, GriffithsJR. HIF-1-independent mechanisms regulating metabolic adaptation in hypoxic cancer cells. Cells2021;10(9):2371; doi: 10.3390/cells10092371
35.
LiM, HuangL, ChenJ, et al.AMPK-activated BAP1 regulates pVHL stability and tumor-suppressive functions. Cell Death Differ2026;33(3):447–464; doi: 10.1038/s41418-025-01590-9
36.
LinRW, HoCJ, ChenHW, et al.P53 enhances apoptosis induced by doxorubicin only under conditions of severe DNA damage. Cell Cycle, 2018;17(17):2175–2186; doi: 10.1080/15384101.2018.1520565
37.
LiuK, WangY, LiH. The role of ninjurin1 and its impact beyond the nervous system. Dev Neurosci2020;42(5–6):159–169; doi: 10.1159/000512222
38.
LyuYL, KerriganJE, LinCP, et al.Topoisomerase IIbeta mediated DNA double-strand breaks: Implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Res2007;67(18):8839–8846; doi: 10.1158/0008-5472.Can-07-1649
39.
MaroltU, Paradiž LeitgebE, PohorecV, et al.Calcium imaging in intact mouse acinar cells in acute pancreas tissue slices. PLoS One2022;17(6):e0268644; doi: 10.1371/journal.pone.0268644
40.
MittalM, SiddiquiMR, TranK, et al.Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal2014;20(7):1126–1167; doi: 10.1089/ars.2012.5149
41.
ModyH, VaidyaTR, Ait-OudhiaS. In vitro to clinical translational pharmacokinetic/pharmacodynamic modeling of Doxorubicin (DOX) and Dexrazoxane (DEX) interactions: Safety assessment and optimization. Sci Rep2023;13(1):3100; doi: 10.1038/s41598-023-29964-4
42.
MohammadiM, ArabiL, AlibolandiM. Doxorubicin-loaded composite nanogels for cancer treatment. J Control Release2020;328:171–191; doi: 10.1016/j.jconrel.2020.08.033
43.
MukhopadhyayP, RajeshM, BáTKAIS, et al.CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. Cardiovasc Res2010;85(4):773–784; doi: 10.1093/cvr/cvp369
44.
ParkSY, KimMW, KangJH, et al.Loss of ninjurin1 alleviates acetaminophen-induced liver injury via enhancing AMPKα-NRF2 pathway. Life Sci2024;350:122782; doi: 10.1016/j.lfs.2024.122782
45.
RamosS, HartenianE, BrozP. Programmed cell death: NINJ1 and mechanisms of plasma membrane rupture. Trends Biochem Sci2024;49(8):717–728; doi: 10.1016/j.tibs.2024.05.007
46.
SemenzaGL. The genomics and genetics of oxygen homeostasis. Annu Rev Genomics Hum Genet2020;21:183–204; doi: 10.1146/annurev-genom-111119-073356
47.
ShengY, WuL, ChangY, et al.Tomo-seq identifies NINJ1 as a potential target for anti-inflammatory strategy in thoracic aortic dissection. BMC Med2023;21(1):396; doi: 10.1186/s12916-023-03077-1
48.
ShiJ, ZhaoY, WangK, et al.Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature2015;526(7575):660–665; doi: 10.1038/nature15514
49.
SongCH, KimN, NamRH, et al.Ninjurin1 deficiency differentially mitigates colorectal cancer induced by azoxymethane and dextran sulfate sodium in male and female mice. Int J Cancer2025;156(4):826–839; doi: 10.1002/ijc.35225
50.
SongboM, LangH, XinyongC, et al.Oxidative stress injury in doxorubicin-induced cardiotoxicity. Toxicol Lett2019;307:41–48; doi: 10.1016/j.toxlet.2019.02.013
51.
SteinbergGR, HardieDG. New insights into activation and function of the AMPK. Nat Rev Mol Cell Biol2023;24(4):255–272; doi: 10.1038/s41580-022-00547-x
52.
SyukriA, HattaM, AmirM, et al.Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-α and VEGF pathway in progressive of cardiovascular damage. Ann Med Surg (Lond)2022;76:103501; doi: 10.1016/j.amsu.2022.103501
53.
TomaL, SandaGM, StancuCS, et al.Oscillating glucose induces the increase in inflammatory stress through ninjurin-1 up-regulation and stimulation of transport proteins in human endothelial cells. Biomolecules2023;13(4):626; doi: 10.3390/biom13040626
54.
UpshawJN, ParsonSK, BuchsbaumRJ, et al.Dexrazoxane to prevent cardiotoxicity in adults treated with anthracyclines: JACC: CardioOncology controversies in cardio-oncology. JACC CardioOncol2024;6(2):322–324; doi: 10.1016/j.jaccao.2024.02.004
WangGL, JiangBH, RueEA, et al.Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A1995;92(12):5510–5514; doi: 10.1073/pnas.92.12.5510
57.
WangJ, ZhangY, ChenQ, et al.Penfluridol enhances anti-tumor immunity in colorectal cancer by inducing proteasome-mediated degradation of PD-L1 via the activation of AMPK. Transl Oncol2025;62:102559; doi: 10.1016/j.tranon.2025.102559
58.
WarbrickI, RabkinSW. Hypoxia-inducible factor 1-alpha (HIF-1α) as a factor mediating the relationship between obesity and heart failure with preserved ejection fraction. Obes Rev2019;20(5):701–712; doi: 10.1111/obr.12828
59.
WooJK, JangYS, KangJH, et al.Ninjurin1 inhibits colitis-mediated colon cancer development and growth by suppression of macrophage infiltration through repression of FAK signaling. Oncotarget2016;7(20):29592–29604; doi: 10.18632/oncotarget.9020
60.
WuZ, XuZ, PuH, et al.NINJ1 facilitates abdominal aortic aneurysm formation via blocking TLR4-ANXA2 interaction and enhancing macrophage infiltration. Adv Sci (Weinh)2024;11(31):e2306237; doi: 10.1002/advs.202306237
61.
YarmohammadiF, KarimiG. An updated overview on targeting Nrf2 by natural compounds against doxorubicin-induced cardiotoxicity. Phytother Res2026; doi: 10.1002/ptr.70290
62.
YunHJ, LiM, GuoD, et al.AMPK-HIF-1α signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth. J Exp Clin Cancer Res2023;42(1):340; doi: 10.1186/s13046-023-02927-3
63.
ZhangK, GanJ, WangB, et al.FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice. Nat Commun2025;16(1):1661; doi: 10.1038/s41467-025-56885-9
64.
ZhangS, LiuX, Bawa-KhalfeT, et al.Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med2012;18(11):1639–1642; doi: 10.1038/nm.2919
65.
ZhangX, ChenY, WangX, et al.NINJ1 triggers extravillous trophoblast cell dysfunction through blocking the STAT3 signaling pathway. Genes Genomics2022;44(11):1385–1397; doi: 10.1007/s13258-022-01313-1
66.
ZhangX, GaoYP, DongWS, et al.FNDC4 alleviates cardiac ischemia/reperfusion injury through facilitating HIF1α-dependent cardiomyocyte survival and angiogenesis in male mice. Nat Commun2024;15(1):9667; doi: 10.1038/s41467-024-53564-z
67.
ZhangY, CaoL, ZhangR, et al.Oxidative stress as the orchestrator of the HIF axis switch in intracerebral hemorrhage. Free Radic Biol Med2026;244:312–322; doi: 10.1016/j.freeradbiomed.2025.12.011
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
